Continuing education events like this represent a critical need in healthcare as most medical schools still provide minimal cannabis medicine training. Clinicians across specialties are encountering patients using cannabis therapeutically but lack evidence-based frameworks for guidance.
Drexel University’s Elkins Park Campus is hosting a continuing education program on medical marijuana clinical care. The timing reflects growing recognition that healthcare providers need formal training in cannabis medicine as more states establish medical programs and patient usage increases. Such programs typically address regulatory frameworks, evidence-based applications, drug interactions, and clinical decision-making protocols.
“I’m encouraged to see academic medical centers stepping up with formal cannabis education. Most practicing physicians received zero cannabis training in medical school, yet patients are using it daily and asking for guidance.”
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
Table of Contents
FAQ
What is the clinical relevance rating of this cannabis news update?
This update has been assigned CED Clinical Relevance #76 with “Notable Clinical Interest” status. This indicates emerging findings or policy developments that healthcare professionals should monitor closely.
What topics does this cannabis news cover?
The news focuses on medical education, clinical training, healthcare policy, and professional development related to cannabis medicine. These areas are essential for healthcare providers working with cannabis therapeutics.
Who is the target audience for this information?
This content is primarily aimed at healthcare professionals, clinicians, and medical educators involved in cannabis medicine. It’s also relevant for those developing healthcare policies around cannabis use.
Why is this classified as “Notable Clinical Interest”?
The classification suggests this contains emerging findings or policy developments in cannabis medicine that warrant close attention from the clinical community. Such updates often influence practice guidelines or treatment approaches.
What should healthcare professionals do with this information?
Healthcare professionals should review these developments to stay current with evolving cannabis medicine practices and policies. This information may impact clinical decision-making, training protocols, or professional development planning.